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Abstract 
 
C5a is a potent proinflammatory agonist that mediates renal ischaemia reperfusion (IR) injury, but 
the potential for modulating chronic post ischaemic fibrosis and use of therapeutic antagonist is 
undefined. Here we show that C5a receptor 1 (C5aR1) signalling is essential to the development of 
post-ischaemic fibrosis and is a valid target for therapeutic blockade with soluble receptor antagonist. 
In the present study, we show that C5aR1 is required for the development of renal tubulointerstitial 
fibrosis in a murine model of renal IR injury. Deficiency of C5aR1 protected mice from the 
development of the fibrosis. The protection was associated with attenuated deposition of 
extracellular matrix components (fibronectin, collagen I), reduced cellular infiltrates (CD45, F4/80) 
and gene expression of proinflammatory and profibrogenic mediators in the kidney. In an in 
vitro model of hypoxia/reoxygenation, C5a stimulation caused renal fibroblast proliferation and 
activation, and upregulated gene expression of IL-1β, IL-6, TGF-β in renal tubular epithelial cells and 
monocytes/macrophages. Administration of C5aR1 antagonist (PMX53) significantly reduced renal 
injury and tubulointerstitial fibrosis. Our results demonstrate a pathogenic role for C5aR1 in 
progression of tubulointerstitial fibrosis following renal IR injury and provide evidence supporting that 
C5aR1 mediated-local inflammatory responses to hypoxic renal injury contribute to tubulointerstitial 
fibrosis through several cellular pathways, namely, promoting tubule injury, interstitial fibroblast 
proliferation and epithelial-to-mesenchymal transition of renal tubular epithelial cells. Our results 
also suggest the C5a-C5aR1 interaction is a therapeutic target for chronic post ischaemic fibrosis.   
 
 
Introduction 
 
Progressive tubulointerstitial fibrosis is the final common pathway for many chronic kidney diseases 
(CKD) leading to end-stage renal failure. Acute kidney injury (induced for example by such as 
ischemic insult, systemic inflammation and sepsis) is one of the main causes of CKD, among other 
causes (e.g. diabetes and hypertension, infections, glomerulonephritis, renal vasculitis)1. Renal 
ischemia reperfusion (IR) injury is an inevitable consequence of kidney transplantation and 
contributes to the progression of graft dysfunction and renal fibrosis 2. As there are currently no 
specific treatments for tubulointerstitial fibrosis, identifying key mediators of renal fibrosis will be 
beneficial to the development of effective strategies that prevent or limit the fibrosis in chronic 
inflammatory states. 
 
Tubulointerstitial fibrosis is characterized by progressive replacement of the normal architecture of 
tubules is progressively replaced with extracellular matrix (ECM) including collagen I (COL I) and 
fibronectin (FN). Excessive deposition of those proteins leads to structural and functional change of 
the kidney parenchyma and eventually renal dysfunction 3. The major cell type of producing ECM is 
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the myofibroblast which produces a large amount of COL I and FN 4, 5. Myofibroblasts mainly 
differentiate from renal interstitial fibroblasts, other types of cells in the kidney such as bone marrow-
derived fibrocystic and stromal mesenchymal cells, and renal tubular epithelial cells have been 
reported to be able to transform into myofibroblasts 6. The pathogenesis of tubulointerstitial fibrosis 
involves many elements (i.e. cytokines, growth factors, leukocytes, activation of fibroblasts, 
epithelial-to-mesenchymal transition [EMT]) are thought to contribute to the development of 
progressive tubulointerstitial fibrosis 7, 8. However, recent research has highlighted the role of the 
interstitial fibroblast and its activation and differentiation into myofibroblast in promoting renal 
tubulointerstitial fibrosis, excessive or persistent inflammation being an important driver of fibroblast 
activation4, 5, 9.  
 
Complement activation occurs rapidly in response to hypoxic renal injury and other types of noxious 
agents including physical and chemical stress 10-12. C5a, generated during complement activation is 
a potent inflammatory mediator which attracts leukocytes to the site of the injury. Through binding to 
its specific receptor complement C5a receptor 1 (C5aR1), which is expressed on wide variety of cells 
including myeloid and non-myeloid cells, C5a triggers the release of inflammatory cytokines and 
other substances inducing local inflammation. Thus, C5a/C5aR1 interactions play important roles in 
regulating/coordinating many inflammatory and immunological processes that contribute to the 
pathogenesis of a wide range of inflammatory and immunological diseases 13-15. 
 
Previous studies by us and others have shown that C5a/C5aR1 interactions mediate the 
pathogenesis of renal IR injury and allograft rejection 13, 16-18. However, little is known about the role 
of C5aR1 in progression of tubulointerstitial fibrosis following renal IR injury and the underlying 
mechanisms. Given early inflammatory responses to hypoxic renal injury not only cause tissue 
damage, but also contribute to chronic inflammation and chronic graft dysfunction, we hypothesised 
that C5a/C5aR1 interactions could play a role in progression of tubulointerstitial fibrosis following 
renal IR injury and could provide a tractable therapeutic target. 
 
In the present study, we employed a murine model of renal IR injury in C5aR1-/- mice to determine 
the role of C5aR1 in the development of renal tubulointerstitial fibrosis. We also performed a series 
of ex vivo analyses and in vitro experiments (using primary cultures of murine renal tubular epithelial 
cells [RTEC], renal fibroblasts and peritoneal exudate leukocytes) to explore the mechanisms by 
which C5a/C5aR1 interactions influence the development of tubulointerstitial fibrosis. Our results 
demonstrate a pathogenic role for C5aR1 in the development of tubulointerstitial fibrosis and suggest 
that C5a/C5aR1 interactions promote progression of the fibrosis through mediating local 
inflammatory responses and directly stimulating renal fibroblasts. 
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Results 
 
C5aR1-/- mice have reduced renal tubulointerstitial fibrosis following renal IR insult 
We first examined the time-kinetics of the development of the fibrosis in WT mice following renal IR 
insult which was induced by clamping renal arteries and veins bilaterally for 35 min. Renal 
tubulointerstitial fibrosis was assessed at 5, 10 and 20 days after reperfusion by Sirius red (SR) and 
Masson’s trichrome (MT) staining. The degree of tubulointerstitial SR- or MT-positively stained area 
was increased over this period, with a sharp increase at day 10 (Figure 1A), indicating the day 10 
after reperfusion is a suitable time point for analysing tubulointerstitial fibrosis in this model. Next, 
we assessed the fibrosis in WT and C5aR1-/- mice at day 10 after reperfusion. SR staining showed 
that the positively stained area was significantly reduced in C5aR1-/- kidneys, compared to WT 
kidneys, indicating a reduced tubulointerstitial deposition of extracellular matrix (ECM) in C5aR1-/- 
kidneys (Figure 1B, C). Immunohistochemistry further showed that C5aR1-/- kidneys had a reduced 
deposition of collagen I (COL I) and fibronectin (FN), compared to WT kidneys (Figure 1D, E). 
Consistent with the immunohistochemistry results, RT-qPCR showed that intrarenal gene 
expression levels of COL I and FN were significantly lower in C5aR1-/- mice than in WT mice (Figure 
1F). We also monitored the changes of renal function at 5, 10 and 20 days after reperfusion by 
measuring BUN levels. Renal function at days 5 and 10 was better preserved in the deficient mice 
compared to WT, but the difference was less apparent by day 20 after the acute IR injury (Figure 
1G). Thus, C5aR1 deficient mice had reduced renal tubulointerstitial fibrosis and better preserved 
renal function following renal IR insult, suggesting pathogenic roles for C5aR1 in the development 
of renal tubulointerstitial fibrosis. 
 
C5aR1 deficiency has an impact on leukocyte infiltration and macrophage phenotype in the 
kidney following renal IR insult 
Renal interstitial leukocyte infiltration is a hallmark of renal inflammation in renal IR injury. We 
therefore assessed the impact of C5aR1 on leukocyte infiltration and macrophage phenotype in the 
kidneys through to the chronic phase after renal IR insult. Our previous study (of the acute injury) 
has shown that the basal levels of renal leukocytes in normal WT and C5aR1-/- mice were 
comparable16. Here, flow cytometry analysis showed that C5aR1-/- mice had significantly less 
CD45+ (total leukocytes) and F4/80+ (macrophages) cells at 5, 10 and 20 days after reperfusion, 
compared to WT mice (Figure 2A-D). Macrophage phenotype plays an important role in the 
processes of tissue repair and fibrosis following acute kidney injury 9. Previous studies have 
suggested that CD11b+F4/80low cells are M1 like macrophages, while CD11b+F4/80high are M2 like 
macrophages 19, 20. We therefore further analysed macrophage phenotype in the kidneys of WT and 
C5aR1-/- mice at day 10 after reperfusion. Flow cytometry analysis showed that C5aR1-/- kidneys 
had significantly more F4/80high cells and less F4/80low cells as well as higher ratio of F4/80high to 
F4/80low, in the CD11b+ compartment, compared to WT kidneys (Figure 2E-F). These data 
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demonstrate that C5aR1 deficiency not only reduced leukocyte infiltration but also favoured the 
differentiation of M2-like phenotype versus M1-like phenotype in macrophages. 
 
C5aR1-/- mice have reduced intrarenal gene expression of proinflammatory and profibrotic 
mediators following renal IR insult 
C5aR1 signalling is responsible for inflammatory responses in the acute phase of renal IR injury 13, 
16
. However, its involvement in renal tissue inflammation and fibrogenesis in the late phase of the 
injury is less certain. We therefore assessed the impact of C5aR1 on renal tissue inflammation and 
fibrogenesis by performing RT-PCR for the molecules relevant to renal fibrosis in kidneys of WT and 
C5aR1-/- mice at 5 and 10 days after reperfusion. Intrarenal mRNA levels of pro-inflammatory 
cytokines (IL-1β, TNF-α), chemokine (MCP-1) and chemokine receptor (CCR2) were significantly 
lower in C5aR1-/- mice compared to WT mice (Figure 3A). Conversely, intrarenal mRNA levels of 
anti-inflammatory cytokine (IL-10) were higher in C5aR1-/- mice (Figure 3B). Intrarenal mRNA levels 
of profibrogenic mediators (TGF-b, PDGF) were also lower in C5aR1-/- mice than in WT mice, which 
correlates well with observed changes in pro-inflammatory mediators (Figure 3C). These results 
indicate that C5aR1 deficiency resulted in a reduction of intrarenal expression of pro-inflammatory 
and profibrogenic mediators in the late phase of renal IR injury, suggesting a role for C5aR1 in tissue 
inflammation and fibrogenesis.  
 
C5aR1-/- mice exhibit an attenuated epithelial-to-mesenchymal transition of renal tubular 
epithelial cells following renal IR insult 
Epithelial-to-mesenchymal transition (EMT) is recognised as an integral part of tissue fibrogenesis 
after injury 6, which is often triggered by and associated with chronic/persistent local inflammation 7. 
Given that C5a/C5aR1 interactions are an important driver of inflammation, and C5aR1-/- mice had 
decreased renal tissue inflammation in the late phase of renal IR injury as observed above, we 
hypothesised that C5aR1 deficiency attenuates EMT of tubular epithelial cells following renal IR 
insult. We performed immunohistochemistry for E-cadherin (E-Cad, an epithelial marker) and 
fibroblast-specific protein 1 (FSP-1, a mesenchymal marker) in the injured kidneys of WT and 
C5aR1-/- mice (10 days after reperfusion). C5aR1-/- kidneys exhibited higher E-Cad and lower FSP-
1 expression (Figure 4A, 4B) as well as significantly lower ratio of FSP-1 to E-Cad expression 
compared to WT kidneys (Figure 4C), suggesting a reduction of EMT of RTEC in C5aR1-/- mice 
following renal IR insult.  
 
C5a up-regulates pro-inflammatory cytokine and pro-fibrotic factor production by hypoxia 
stressed-RTEC and - MO/MΦ in vitro 
RTEC and monocytes/macrophages (MO/MΦ) are an important source of proinflammatory and 
profibrogenic mediators 21, 22. Our previous study has shown that C5a stimulation increases the 
murine IL-8 homologues (KC) and TNF-α production by macrophages and RTEC under hypoxia-
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reoxygenation conditions16. Here, we assessed the effects of C5a on hypoxia/reoxygenation-induced 
production of several additional proinflammatory and profibrogenic mediators (i.e. IL-1β, IL-6 and 
TGF-β) by these two types of cells. RT-qPCR showed that mRNA levels of these mediators were 
significantly increased in RTEC and MO/MΦ following C5a stimulation (Figure 5). These results 
demonstrate that C5a has direct effects on RTEC and MO/MΦ to up-regulate proinflammatory 
cytokine and profibrogenic mediator production under hypoxia-reoxygenation condition. 
 
C5a stimulates renal fibroblast proliferation and ECM production 
The activation of interstitial fibroblasts to become myofibroblasts is an essential step in the 
development of renal fibrosis. Expression of C5aR1 has been reported in fibroblast of lung and 
periodontium 23, 24. We hypothesised that renal fibroblasts may also express C5aR1 and C5a/C5aR1 
interactions may have effects on cell proliferation and activation. To test this, we first confirmed the 
expression of C5aR1 in primary renal fibroblasts by immunocytochemistry and RT-PCR. 
Immunochemical staining showed that renal fibroblasts exhibited a fibroblast-like morphology and 
positive staining for the mesenchymal marker vimentin, and C5aR1 was clearly detected in these 
cells (Figure 6A). Expression of C5aR1 in renal fibroblasts was further confirmed by RT-PCR. 
Results showed that C5aR1 was detected under normal conditions and the expression was 
increased in response to hypoxic stress (Figure 6B, 6C). Next, we assessed the effect of C5a on 
renal fibroblast proliferation and ECM production. Proliferation assay showed that addition of C5a 
increased the proliferation of renal fibroblasts (Figure 6D). RT-qPCR showed that addition of C5a 
upregulated gene expression of COL I, FN and αSMA in renal fibroblasts (Figure 6E). These data 
suggest that C5a/C5aR1 interaction has a stimulatory effect on renal fibroblast proliferation and 
activation. 
 
Blocking C5aR1 with antagonist (PMX53) protects mice from developing renal 
tubulointerstitial fibrosis following renal IR insult 
Having shown that C5a/C5aR1 interactions are required for the development of tubulointerstitial 
fibrosis by using C5aR1-/- mice, next we explored the therapeutic potential of targeting C5aR1 in 
tubulointerstitial fibrosis. We employed PMX53 (a recognized C5aR1 antagonist) in our renal IR 
injury mouse model. PMX53 treatment (i.p. daily) started on the day before the induction of injury 
significantly reduced tubulointerstitial deposition of ECM (as measured by SR staining and 
immunohistochemistry for COL I and FN) and tubule damage (as measured by LTL staining) (10 
days after reperfusion) (Figure 7A-D). A concomitant improvement in renal function was observed in 
PMX53 treated mice compared with control-treated group (Figure 7E). We also examined if delayed 
administration of PMX53 would reduce renal fibrosis following renal IR insult and performed an 
additional set of experiments including three groups of mice: i) control treatment, ii) PMX53 treatment 
starting at day 0 (d0-d9), iii) PMX53 treatment starting at day 3 (d3-d9). Renal fibrosis and function 
were assessed 10 days after reperfusion. Intrarenal gene expression of COL I and FN and 
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tubulointerstitial deposition of ECM were reduced in both PMX53 treatment groups compared to 
control-treated group, this was accompanied by improvement in renal function in both PMX53 
treatment groups. PMX53 treatment starting at day 0 appears more effective than the treatment 
starting at day 3 (Figure 7F-H). Together, these results demonstrate that blocking C5aR1 with 
antagonist confers protection against the development of renal fibrosis following renal IR insult. The 
results were consistent with the observations in C5aR1-/- mice, further confirming a role of C5aR1 
in the development of tubulointerstitial fibrosis.  
 
 
Discussion 
 
Inflammatory responses to hypoxia can cause tissue damage and contribute to tissue fibrosis and 
chronic renal dysfunction. Identification of key mediators of inflammatory responses driving fibrotic 
process following renal IR injury may lead to improvement of renal function through specific 
intervention. Although there is compelling evidence on the pathogenic roles of C5a/C5aR1 signalling 
in acute renal IR injury, graft dysfunction and allograft rejection 16-18, the impact of the signalling on 
progression of renal fibrosis following renal IR injury has been unclear. The present study provides 
evidence that C5a/C5aR1 signalling is required for the development of tubulointerstitial fibrosis 
following renal IR insult, thus, supporting a pathogenic role for C5a/C5aR1 signalling in renal fibrosis. 
This also suggests a potential link between C5aR1 dependent renal IR injury and chronic transplant 
dysfunction, where a role for C5aR1 signalling has been implicated in acute post-transplant injury. 
 
Pathogenic roles for C5aR1 in renal fibrosis have been reported in the unilateral ureteral obstruction 
model and chronic pyelonephritis model in mice by us and others 22, 25, 26. However, the insults in 
those models are different from the insult in this study; the kinetics of cellular responses to the insult, 
the major pathological parameters and the involved mechanisms in those models might be different 
from that in IR injury model. In the present study, we performed a series of in vivo experiments to 
titrate the kinetics of interstitial collagen deposition following renal IR injury. We found that the d10 
after reperfusion is an optimal time point to analyse interstitial collagen deposition by SR, TM and 
immunohistochemistry for COL I and FN, whereas d5 and d10 are optimal time points to analyse 
renal cellular infiltrates and intrarenal gene expression of proinflammatory and pro fibrogenic 
mediators. The results of our in vivo experiments, using mice with genetic deletion or through 
pharmacologic inhibition of C5aR1 and by measuring multiple parameters (i.e. collagen deposition, 
cellular infiltration and intrarenal gene expression, renal function), clearly show that C5aR1 is 
required for the development of tubulointerstitial fibrosis following renal IR insult, thus supporting a 
pathogenic role for C5aR1 in this process. 
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In the present study, in addition to determining the role of C5R1 in tubulointerstitial fibrosis, we 
investigated the mechanisms by which C5a/C5R1 signalling contributes to the pathogenesis of 
tubulointerstitial fibrosis, by focusing specifically on cellular mechanisms. As illustrated in Figure 8, 
our data suggest that, in response to renal IR insult, C5a/C5aR1 interactions may promote 
progression of tubulointerstitial fibrosis through acting on inflammatory cells, renal tubular epithelial 
cells and renal fibroblasts and contributing to the proinflammatory environment in tubulointerstitium 
and fibroblast proliferation/activation. More specifically, first, our ex vivo analysis of injured renal 
tissues showed that C5aR1 deficiency not only reduced leukocyte infiltration and macrophage 
accumulation, but also favoured the differentiation of macrophages into a M2-like phenotype, this is 
associated with a concomitant reduction in intrarenal gene expression of proinflammatory and 
profibrogenic mediators. These results provide support for the roles of C5aR1 in mediating local 
inflammation and promoting M1 macrophage in this model, it also suggests a pathogenic role for M1 
macrophage in progression of tubulointerstitial fibrosis following renal IR insult, which is in 
agreement with several published studies that suggest M1 macrophage drives renal fibrosis after 
AKI, while M2 macrophage is necessary for recovery from AKI 27-29. On the contrary, some studies 
also suggested that M2 like macrophages may contribute to renal fibrosis, particularly in the chronic 
phase of kidney injury 30, 31, thus highlighting the complicated role of different macrophage subsets 
in renal repair/fibrosis, more studies on M1/M2 subsets and their relation to in vivo recovery process 
from AKI are needed. In addition, our results obtained from in vitro hypoxia experiments showed that 
the production of proinflammatory and profibrogenic mediators in MO/MΦ was significantly 
upregulated by C5a stimulation. These results suggest that C5a/C5aR1 signalling, as a potent 
inflammatory mediator, mediates recruitment and activation of inflammatory cells, thus leading to a 
proinflammatory environment which may not only cause tubule injury and EMT of RTEC, but also 
stimulate renal fibroblasts. Second, in addition to the effects on inflammatory cells, our results 
obtained from in vitro hypoxia experiments also showed that the production of proinflammatory and 
profibrogenic mediators in RTEC was upregulated by C5a stimulation. In addition, EMT of RTEC in 
the kidney following renal IR insult was markedly reduced in C5aR1-/- mice. These results suggest 
that C5a/C5R1 signalling on RTEC can also contribute to a proinflammatory environment 
responsible for tubule injury, cellular accumulation and EMT. Third, another important finding in our 
in vitro hypoxia experiments is that renal fibroblast proliferation and ECM production were 
significantly enhanced by C5a stimulation, suggesting that C5a/C5R1 signalling can contribute to 
tubulointerstitial fibrosis through its stimulatory effects on renal fibroblast. In agreement with this 
observation, it has been shown that C5a/C5aR1 signalling has direct effects on pulmonary 
fibroblasts which could contribute to the pathogenesis of bleomycin-induced lung fibrosis24. Results 
from our C5aR1 blocking experiments, which show that delayed administration of PMX53 (3 days 
after reperfusion) also reduced renal fibrosis, suggest that C5a/C5aR1 interactions may have direct 
pro-fibrotic effects, independently of the early inflammatory responses they induced.   
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In conclusion, the present study demonstrates a pathogenic role for C5aR1 in tubulointerstitial 
fibrosis following renal IR insult and address the underlying mechanisms of C5aR1 promoting the 
development of tubulointerstitial fibrosis. Furthermore, the findings present in this study, together 
with the findings of previous studies about the pathogenic role of C5aR1 in chronic graft dysfunction 
and allograft rejection, suggest a new avenue for therapeutic targeting in chronic renal or graft injury.  
 
 
Materials and Methods 
 
Mice 
Homozygous C5aR1-/- mice were derived by homologous recombination in embryonic stem cells 32 
and backcrossed onto to C57BL/6 (H-2b) strain for more than 12 generations. WT C57BL/6 mice 
were purchased from Harlan Laboratories (UK). Male mice (8-12 weeks) were used in all the 
experiments. Animal procedures adhered to the Animals (Scientific Procedures) Act of 1986. 
 
Induction of renal IR injury  
Renal IR injury was induced as we previously described with some modifications 33. In brief, mice 
were anesthetized by isoflurane and a midline abdominal incision was made. The renal arteries and 
veins were isolated and bilaterally occluded with micro aneurysm clamps for 35 min. After removal 
of the clamps, 1 ml of warm saline was put in the abdomen and the incision was sutured. Mice were 
kept up to 20 days. In some experiments, mice were treated with C5aR1 peptide antagonist (PMX53) 
34
 or control peptide (1 mg/kg), starting at d0 or d3, daily by intraperitoneal (i.p.) injection. Mice were 
killed 10 days after reperfusion. In some experiments, at day 5, 10 and 20 after reperfusion, blood 
samples were taken for renal function assessment and kidneys were collected for histopathology, 
flow cytometry and RT-qPCR.  
 
Assessment of renal function and fibrosis  
Renal function was determined by measuring the blood urea nitrogen (BUN) in the serum using 
Infinity Urea kit. To assess renal fibrosis, kidney paraffin sections (4 µm) were stained for Sirius red 
and Masson’s trichrome and scanned with a Hamamatsu Nanozoomer 2.0 HT (Hamamatsu 
Photonics, Hamamatsu, Japan) and viewed using NDP.view2 software. Some images were taken in 
the cortical medullary junction using an Olympus BX51 microscope (Japan). The positively stained 
red or blue tissue in each image was quantified by Image J (National Institutes of Health, Bethesda, 
MD, USA) as percentage of positive staining per field (4 fields from 2 sections per kidney were 
analysed). The quantitative analyses were performed in a blinded fashion by 2 experienced persons. 
Collagen deposition was further assessed by immunohistochemistry for Collagen I (COL I) and 
fibronectin (FN).   
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Immunohistochemistry and Immunocytochemistry  
Immunohistochemistry was performed on kidney sections and renal fibroblasts. Prior to the staining, 
the formalin-fixed, paraffin-embedded kidney sections (5 µm) were deparaffinised and rehydrated, 
followed by heat-induced antigen retrieval using sodium citrate or Tris EDTA. The OCT-embedded 
frozen kidney sections (4 µm) were fixed in ice-cold acetone for 5 min, while the primary renal 
fibroblasts grown on the coverslips were fixed in 4% paraformaldehyde for 15 min and permeablized 
by 0.5% Triton X-100 for 10 min. All the tissue or cells were blocked with 10% goat or donkey serum 
for 30 min, followed by an overnight incubation with primary antibodies (for COL I, FN, E-cadherin, 
FSP-1, C5aR1 or vimentin) at 4°C and 1-hour incubation with secondary antibodies (TRITC-
conjugated goat anti-rabbit IgG Ab, FITC-conjugated donkey anti-rabbit or anti-rat IgG Ab, Alexa 
Fluor 568 Donkey anti-goat IgG), LTL (detecting L-fucose in the proximal tubules) and DAPI (staining 
nuclei) at room temperature. The staining of COL I and FN in the cortical medullary junction was 
imaged via an A1R point scanning confocal microscope (Nikon, Japan). Quantification were carried 
out on the images at 600x magnification. The positive staining of E-cadherin and FSP-1 was 
quantified by Image J as fluorescence intensity per field (six fields from 2 sections per kidney at 100x 
magnification).  
 
Induction of hypoxia-reoxygenation injury in RTEC and fibroblasts in vitro 
RTEC and renal fibroblasts were cultured under hypoxic conditions (5% CO2, 1% O2 and 94% N2) in 
a gas chamber for 24 hours to induce hypoxia stress, followed by reoxygenation (21% O2 and 5% 
CO2) for 24, or 48 hours with or without the presence of C5a. In some experiments, total RNA was 
extracted and RT-qPCR was performed to assess the expression of pro-inflammatory molecules (IL-
1β, IL-6, TGF-β) in RTEC and ECM molecule (Col I, FN and αSMA) in renal fibroblasts. 
 
Statistical analysis  
Data are shown as mean ± SD or the readout of individual mice. Unpaired Student's t test was used 
to compare the means of two groups. One-way or Two-way ANOVA was used to compare the means 
of more than two independent groups. All the analyses were performed using Graphpad Prism 7 
software. P < 0.05 was considered to be significant. 
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Figure legends 
Figure 1. C5aR1 deficiency reduces renal tubulointerstitial fibrosis following renal IR insult.  
Renal IR injury was induced in WT and C5aR1-/- mice. Serum samples and kidneys were collected 
at d5, d10 and d20 after reperfusion. (A) Representative images of Sirius red (SR) and Masson’s 
trichrome (MT) staining on normal and injured WT kidneys at varied time points after reperfusion. 
Scale bar: 100 µm. (B) Representative images of SR on injured WT and C5aR1-/- kidneys at d10 
after reperfusion. Scale bar: 50 µm. (C) Quantification of Sirius red-stained areas corresponding to 
the WT and C5aR1-/- mice in (B). Data were analysed by Unpaired two-tailed Student's t test (n=6 
mice per group). (D, E) ECM protein deposition in kidneys. (D) Representative fluorescence 
microscope images of COL I (red), FN (red), and lotus tetragonolobus lectin (LTL) (a proximal tubular 
marker) (green), and DAPI (blue) staining on kidneys of WT and C5aR1-/- mice at d10 after 
reperfusion, taken at the cortical-medullary junction. Arrows indicate positive-stained areas. Scale 
bars: 25 µm. (E) Quantification of positively stained areas of COL I and FN corresponding to the WT 
and C5aR1-/- mice in D. Data are shown as mean ± SD and were analysed by One-way ANOVA 
with multiple comparisons test (n=6-8 viewing fields from 3 mice per group, under x600 
magnification). (F) Relative mRNA levels of COL I and FN in the WT and C5aR1-/- mouse kidneys 
at day 10 after reperfusion, determined by RT-qPCR. Data were analysed by Unpaired two-tailed 
Student's t test (n=5 mice per group). (G) BUN levels in WT and C5aR1-/- mice at d5, d10 and d20 
after reperfusion. Data were analysed by Two-way ANOVA with multiple comparisons test (n=4 to 8 
mice per group, each time point). (C, F, G) Each dot represents an induvial mouse. Dashed line 
represents the BUN level in normal mice. **, P<0.01; ****; P< 0.0001.  
 
Figure 2. Impact of C5aR1 deficiency on leukocyte infiltration and macrophage phenotype in 
the kidney following renal IR insult 
(A-D) Inflammatory cell infiltration in WT and C5aR1-/- kidneys at d5, d10 and d20 after reperfusion, 
determined by flow cytometry. (A) Representative dot plots of CD45+ cells in the WT and C5aR1-/- 
kidneys at d10. (B) Quantification of CD45+ cells at the all-time points. (C) Representative dot plots 
of F4/80+ cells in the WT and C5aR1-/- kidneys at d5. (D) Quantification of F4/80+ cells at the all-
time points. (B, D) Data were analysed by Two-way ANOVA with multiple comparisons test (n=5 
mice per group, each time point). (E) Stepwise gating strategy used in flow cytometric analysis of 
CD11b+F4/80hi and CD11b+F4/80lo cells in kidney tissues. (F, G) Quantification of the proportion of 
F4/80hi and F4/80lo subset in CD11b+ cells and the ratio of these two types of cells in the WT and 
C5aR1-/- kidneys at d10. Data were analysed by One-way ANOVA with multiple comparisons test 
(n=4 mice per group and representative of 2 independent experiments). (B, D, F, G) Each dot 
represents an induvial mouse. *, P<0.05; ***, P<0.001; ****, P<0.0001. 
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Figure 3. C5aR1 deficiency is associated with reduced renal tissue inflammation and 
fibrogenesis following renal IR insult.  
Relative mRNA levels of proinflammatory (A), IL-10 (B) and profibrogenic factors (C) in the WT and 
C5aR1-/- mouse kidneys at d5 and d10 after reperfusion, determined by RT-qPCR. Data were 
analysed by Two-way ANOVA with multiple comparisons test (n=5 mice per group, each time point). 
Each dot represents an induvial mouse. *, P<0.05; **, P<0.01. 
 
Figure 4. C5aR1-/- mice exhibit an attenuated epithelial-to-mesenchymal transition of renal 
tubular epithelial cells following renal IR insult 
Renal IR injury was induced in WT and C5aR1-/- mice. The kidneys were collected at d10 after 
reperfusion. (A) Representative fluorescence microscope images of E-cadherin (E-Cad) (green) and 
FSP-1 (red), and DAPI (blue) staining in kidney sections of WT and C5aR1-/- mice. Scale bar: 100 
µm. (B) Quantification of E-Cad and FSP-1 expression in renal tubules corresponding to the WT and 
C5aR1-/- mice in A by measuring fluorescence intensity using ImageJ, presented as fluorescence 
intensity units (FIU). Data were analysed by One-way ANOVA with multiple comparisons test (n= 4 
mice per group). (C) Ratio of FSP-1 to E-Cad expression in the WT and C5aR1-/- mice. Data were 
analysed by Unpaired two-tailed Student's t test (n=4 mice per group). Each dot represents an 
induvial mouse. *, P<0.05; ****, P<0.0001. 
  
Figure 5. C5a up-regulates pro-inflammatory cytokine and pro-fibrotic factor production by 
hypoxic stressed-RTECs and MO/MΦ in vitro.  
(A) Primary renal tubular epithelial cells (RTECs), and (B) peritoneal monocytes/macrophages 
(MO/MΦ) were undergone hypoxia for 24 hours, followed by 24 hours of re-oxygenation in the 
presence or absence of C5a. Relative mRNA levels of IL-1β, IL-6 and TGF-β were measured by RT-
qPCR. Data are shown as mean ± SD and were analysed by One-way ANOVA with multiple 
comparisons test (n=4 independent experiments). *, P<0.05; **, P<0.01; ***, P<0.001; ****, 
P<0.0001. 
 
Figure 6. C5a stimulates renal fibroblast proliferation and activation.   
(A)Fluorescence microscopy images of primary renal fibroblasts from normal WT mice stained for 
C5aR1 (red), vimentin (green) and nuclear marker DAPI (blue). Scale bar: 10 µm. (B) Detection of 
C5aR1 mRNA in the fibroblasts by RT-PCR. M, DNA ladder. (C) Relative mRNA levels of C5R1 in 
normal and stressed (had undergone hypoxia for 24h) renal fibroblasts, determined by RT-qPCR. 
Data are shown as mean ± SD and were analysed by Unpaired two-tailed Student's t test (n=3 mice 
per group). (D) Proliferation of fibroblasts (that had undergone hypoxia for 24h and followed by C5a 
stimulation for further 48h), assessed by fluorescent reader. Data are shown as mean ± SD and 
were analysed by One-way ANOVA with multiple comparisons test (n=6 readouts from 3 
experiments). (E) Relative mRNA levels of COL I, FN and α-SMA in renal fibroblasts that had 
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undergone 24 hours of hypoxia and 24 hours of re-oxygenation, in the absence or presence of C5a, 
determined by RT-qPCR. Data are shown as mean ± SD and were analysed by One-way ANOVA 
with multiple comparisons test (n=3 independent experiments). *, P<0.05; **, P<0.01. 
 
Figure 7. Administration of C5aR antagonist prevents the progression of renal fibrosis in 
ischemic kidneys.  
(A-E) Renal IR injury was induced in WT mice followed by administrating C5aR1 antagonist PMX53 
or control (PBS), at d0, i.p. daily. Serum samples and kidneys were collected for the analysis at d10 
after reperfusion. (A) Representatives of SR staining of injured kidneys with or without administrating 
the antagonist. Scale bar: 100 µm. (B) Quantitative analysis of collagen deposition in the injured 
kidneys with SR staining. Data are shown as mean ± SD and were analysed by Unpaired two-tailed 
Student's t test (n=4 mice per group). (C, D) Detection of ECM protein (COL I and FN) deposition in 
the kidneys of mice with PMX53 or control treatment (ctrl) (C) Representative fluorescence 
microscope images of COL I (red), FN (red), and lotus tetragonolobus lectin (LTL) staining in the 
cortical medullar junction region of kidney sections. Scale bars: 25 µm. (D) Quantification of 
positively stained areas of COL I and FN corresponding to the control and PMX53 treated mice in C. 
Data were analysed by One-way ANOVA with multiple comparisons test (n=6 viewing fields from 3 
mice per group, under x600 magnification). (E) BUN levels. Data were analysed by Unpaired two-
tailed Student's t test (n=4 mice per group). (F-H) Additional set of experiments for PMX53 treatment 
including three groups of mice: control treatment, PMX53 treatment starting at d0 (d0-d9) and 
PMX53 treatment starting at d3 (d3-d9). Serum samples and kidneys were collected for the analysis 
at d10 after reperfusion. (F) Relative mRNA levels of COL I and FN in the kidneys, determined by 
RT-qPCR. (G) Quantitative analysis of collagen deposition in the kidneys with SR staining. (H) BUN 
levels. Data in F-H were analysed by One-way ANOVA with multiple comparisons test (n=5-6 mice 
per group). (B, E-H) Each dot represents an induvial mouse. The dotted line indicates a normal BUN 
level. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. 
 
Figure 8. Proposed mechanism by which C5a/C5aR1 interactions promote renal 
tubulointerstitial fibrosis  
Complement activation in response to renal IR insult generates C5a, C5a/C5aR1 interactions may 
contribute to progression of tubulointerstitial fibrosis through several cellular pathways, these 
include: i) Recruitment of inflammatory cells and upregulation of the production of pro-
inflammatory/fibrogenic mediators by inflammatory cells, leading to a proinflammatory environment, 
which promotes tubule injury, cellular accumulation, EMT of RTEC and interstitial fibroblast 
proliferation. ii) Upregulation of the production of pro-inflammatory/fibrogenic mediators by renal 
RTEC, also contributing leading to a proinflammatory environment. iii) Direct stimulation of fibroblast 
proliferation and ECM production. 
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